 RR, 0.68; 95% CI, 0.38-1.24;
Supplementary Table I, online only), respectively. Certainty in evidence was very low, reduced owing to methodologic limitations and severe imprecision.
Outcomes at 5 years. When the long-term outcome of
transfemoral CAS vs CEA in symptomatic patients were
examined using a preplanned pooled analysis of individual patient data from four randomized trials,